Equities

Camlin Fine Sciences Ltd

CAMLINFINE:NSI

Camlin Fine Sciences Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)106.20
  • Today's Change1.25 / 1.19%
  • Shares traded421.08k
  • 1 Year change-36.00%
  • Beta1.6399
Data delayed at least 15 minutes, as of Sep 20 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy0
Outperform1
Hold1
Sell0
Strong Sell0

Share price forecast in INR

The 2 analysts offering 12 month price targets for Camlin Fine Sciences Ltd have a median target of 110.00, with a high estimate of 110.00 and a low estimate of 110.00. The median estimate represents a 2.90% increase from the last price of 106.90.
High2.9%110.00
Med2.9%110.00
Low2.9%110.00

Earnings history & estimates in INR

On Aug 12, 2024, Camlin Fine Sciences Ltd reported 1st quarter 2025 losses of -2.03 per share.
The next earnings announcement is expected on Nov 04, 2024.
Average growth rate-38.48%
Camlin Fine Sciences Ltd reported annual 2024 losses of -8.57 per share on May 20, 2024.
Average growth rate+15.30%
More ▼

Revenue history & estimates in INR

Camlin Fine Sciences Limited had 1st quarter 2025 revenues of 3.96bn. This bettered the 3.88bn consensus of the 2 analysts covering the company. This was 2.47% below the prior year's 1st quarter results.
Average growth rate-1.79%
Camlin Fine Sciences Limited had revenues for the full year 2024 of 16.13bn. This was 4.07% below the prior year's results.
Average growth rate+11.78%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.